PortViewPortView
Perseon logo

Perseon (PRSN) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.07-26.67%
52-week range$0.07
$0.05$3.32

What Perseon does

Perseon Corporation, which operated previously as BSD Medical Corporation, was a life sciences firm dedicated to the entire process, from development to servicing, of medical systems. These systems were specifically designed for cancer treatment through thermal therapy. Their flagship product, the MicroThermX® microwave ablation system, leveraged accurately guided microwave energy to ablate diseased soft tissue. The company's distribution network spanned the United States, Europe, and various regions of Asia.

Key metrics

Market cap
$0
P/E (TTM)
-0.03
EPS (TTM)
$-2.59
Beta
10.84
Dividend yield
0.00%
Revenue / share
$0.07
50-day avg
$0.50
200-day avg
$0.60
52-week high
$3.32
52-week low
$0.05

ETFs linked to PRSN

Broad-market and Healthcare sector ETFs an investor holding Perseon is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PRSN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PRSN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Perseon?
Perseon trades under the ticker PRSN on NASDAQ.
Which exchange is PRSN listed on?
PRSN is listed on NASDAQ.
What sector does Perseon operate in?
Perseon is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze PRSN in a portfolio?
PortView shows PRSN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.